Shanghai, China · Founded 2021 · Privately Held (backing)
Developer of immunotherapy drugs for treatment of cancer. ITabMed is based in Shanghai, China and was founded in 2021. It has raised $20 million.
Last price · $/share
—
Implied valuation
—
Total raised
$20.0M
Last round
—
Cap table — not yet on record
ITabMed's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ITabMed with a free account
·Watch ITabMed: the Monday email on marks, rounds and moves
